cardiology News
-
IFEMA will host the ESC Congress in 2025
In 2025, IFEMA will host the annual congress of the European Society of Cardiology, ESC Congress 2025, the largest congress in the world in this speciality, the holding of which will give Madrid a strong boost, confirming the city as a preferred international destination for business tourism. This has been confirmed by the European Society of Cardiology, which annually celebrates its congress, ...
-
QRS-Blue Now Available
The new QRS-Blue hardware is now available from PBI! Boasting the same features that have made the QRS-Card Cardiology Suite the premier PC-based ECG in the industry, the QRS-Blue hardware in addition now offers wireless Bluetooth connectivity to your PC, phone or tablet. To learn more or inquire about a purchase please see our contact ...
-
Arterius Welcomes New Clinical Advisers
Arterius are pleased to welcome Prof. Patrick Serruys and Dr. Yoshi Onuma to our clinical advisory board. Prof. Serruys (Imperial College, London) will become chair of the clinical advisory board, also now featuring Dr. Onuma (Cardialysis, Netherlands) and Dr. Rasha Al-Lamee (Imperial College, London). Prof. Patrick W. Serruys is is a professor of Interventional Cardiology at the ...
-
Sokolov, Czech Republic - Surgeons testing SOLOASSIST II
The SOLOASSIST II robotic assistant is expanding its range of applications in Russia. On 26th of March 2020 it was first used in the endoscopic separation of the internal thoracic artery by specialists of Clinical Unit 3. The operation was performed at the Federal State Budgetary Institution "NMIC Cardiology" of the Russian Ministry of Health. The doctors noted the exceptional simplicity and ...
-
Mathilda has a special heart
The story of the first patient implanted with a reSept ASD Occluder in Switzerland has been reported in Forschungs-Magazin, the research magazine by Children’s Hospital Zurich, where Mathilda’s intervention took place. In a heartfelt recollection, Mathilda’s family shared their journey from diagnosis, through to coronavirus and travel restrictions, to the operation with a novel ...
-
IFEMA MADRID will held Heart Failure Congress in 2022
This announcement comes a few months after the ESC selected the Institution as host venue for its global congress for 2025, confirming the attractiveness of IFEMA MADRID and Madrid as a host city for large high-level medical congresses. The HFA comprises more than 10,000 members, and past Heart Failure congresses have hosted 5,500 to 6,000 delegates at their in-person editions. The ...
-
BlueRock Therapeutics to Present at 2019 Cell & Gene Meeting on the Mediterranean
BlueRock Therapeutics, LP, an engineered cell therapy company leveraging its novel CELL+GENE™ platform to develop regenerative medicines for intractable diseases, today announced its participation in the inaugural Cell & Gene Meeting on the Mediterranean to be held April 23-25 in Barcelona, Spain. Emile Nuwaysir, Ph.D., President and Chief Executive Officer of BlueRock, and Vice ...
-
vMap`s Role in Optimizing Non-Invasive Radio-Ablation Therapy presented at ACC.21 and THRS 2021.
A dual-center study reported that vMap™, as part of a new, non-invasive workflow - with Varian’s CRA system - improved efficiency and precision for radio-ablation therapy in these study subjects. The study showed that the radio-ablation administered as a part of the enhanced workflow also significantly reduced ICD shocks for patients receiving the therapy. Presented by its lead ...
-
The long-term solution for stressed New York hearts
Avicenna Cardiology is located on Park Avenue in Manhattan, New York. The clinic is led by Dr. Azadeh Beheshtian, board certified in cardiovascular disease and internal medicine by the American Board of Internal Medicine. Dr. Beheshtian specializes in interventional cardiology and peripheral artery disease, providing top-quality heart care and promoting self-preventive cardiology. Avicenna has ...
-
Cardior Pharmaceuticals: Pioneering Study Confirms Pivotal Role of Antisense microRNA Approach in the Treatment of Pathologic Hypertrophy of the Heart
Hanover, Germany, June 24, 2021 - Cardior Pharmaceuticals GmbH, a clinical-stage biotech company focused on the development of non-coding RNA (ncRNA) based therapeutics for patients with cardiovascular diseases, announced today that results from a recent peer-reviewed study underlining the Company´s pioneering approach in the treatment of cardiac diseases were published in the Journal of ...
-
BlueRock Therapeutics to Participate at Upcoming Conferences
BlueRock Therapeutics, LP, an engineered cell therapy company leveraging its novel CELL+GENE™ platform to develop regenerative medicines for intractable diseases, today announced that the company will present at the following upcoming conferences. Presentation details are as follows: BIO International Convention Corporate Presentation Date: Tuesday, June 4, 2019 Time: 2:15 p.m. EDT ...
-
reSept ASD Occluder implanted in EU for the first time
French TV France3 reported on the first patients implanted with a reSept ASD Occluder in France and in the European Union at Bordeaux University Hospital. The coverage includes video interviews with young patient Léo and his mother, and with the doctors that treated him, as part of the ASCENT ASD trial. Professor Jean-Benoît Thambo, head of the department of pediatric and congenital ...
-
Showcase
Corify Care raises €2.35M to translate its cardiac mapping technology to the market. .
- Corify Care is developing ACORYS®, a non-invasive cardiac mapping medical device to transform the cardiac arrhythmia treatment process. - The investment round is led by Clave Capital, counting with investment from CDTI through its Innvierte program and the support from Genesis Biomed. Corify Care, the developer of an innovative and completely non-invasive cardiac mapping system, ...
-
Alleviant Medical Announces Presentation of Clinical Data at American College of Cardiology and EuroPCR Conferences
Alleviant Medical Inc., a privately-held medical device company, today announced one-month and three-month follow up data from the first in human clinical study (ALLEVIATE-HF-1) of its technology for the treatment of heart failure with preserved ejection fraction (HFpEF). The Alleviant System is a novel transcatheter device for the creation of a therapeutic interatrial shunt without a permanent ...
-
World Leading Cardiac Specialists Join Celixir Scientific Advisory Board To Form Innovative Cardiovascular Medicines Collaboration
Celixir (formerly Cell Therapy Limited) today announced the formation of the Innovative Cardiovascular Medicines Collaboration. The Collaboration includes world-leading expertise in cardiac research and clinical development, with the purpose of better understanding the basis for cardiac regeneration. The Collaboration will be jointly led by Professor Kim Fox, Consultant Cardiologist and ...
By Celixir plc
-
AKI Burden of Illness Data Presented at Premier Breakthroughs Conference
Osprey Medical (ASX: OSP) today announces that Dr Anand Prasad, M.D., Director of the Cardiac Catheterization Laboratory at University Health System and Associate Professor of Medicine at UT Health Science Centre at San Antonio, Texas presented the Acute Kidney Injury (AKI) Burden of Illness Study1 at the Premier Breakthroughs 2019 Conference and Exhibition in Nashville, Tennessee on behalf of ...
-
Leading cardiology clinics in Tampa roll out Coala Heart Monitor program
Tampa Cardiovascular Associates is one of the leading cardiovascular groups on the east coast of Florida. The physicians and employees of Tampa Cardiovascular Associates are committed to providing their patients with the best available programs for the prevention, diagnosis, and treatment of artery and vein diseases. The Coala Heart Monitor is now available for prescription at the multiple ...
-
DurAVR accepted into TCT innovation session
Anteris Technologies Ltd (ASX: AVR) (Anteris or the Company) announces its submission at this year’s Transcatheter Cardiovascular Therapeutics (TCT) conference at Orlando, Florida, United States was accepted into the innovation session. The TCT conference, running from November 4 to 6, is the largest and most prestigious Interventional cardiology meeting held each year and will return to ...
-
Saranas Announces Peer-Reviewed Publications Highlighting Accuracy And Clinical Utility Of Early Bird Bleed Monitoring System
Saranas, Inc., developer of the Early Bird® Bleed Monitoring System for the monitoring and early detection of internal bleed complications during endovascular procedures, announced the online publication of two peer-reviewed articles highlighting the system’s accuracy and performance. The publications provide evidence of the Early Bird’s reliability to detect the early onset and ...
-
EchoNous Partners with Us2.ai for Machine Learning-enabled Analysis of Heart Scans
EchoNous, the leader in ultra-portable, AI-guided point-of-care ultrasound (POCUS) tools and software, announced that the company has partnered with Singapore-based Us2.ai, developers of machine learning-driven software that automates the analyses of echocardiographic imagery and measurements. Us2.ai’s technology received FDA approval on July 27, 2021 Us2.ai’s software is being ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you